Skip to main content

Table 1 Pulmonary functions on etodolac and placebo treatments in patients with sinobronchial syndrome.

From: Role of COX-2 in cough reflex sensitivity to inhaled capsaicin in patients with sinobronchial syndrome

  Run-in Placebo Wash out Etodolac
FVCs as % pred. (%) 106.7 ± 4.3 108.8 ± 4.1 106.6 ± 4.4 112.5 ± 1.2
FEV1 s as % pred. (%) 119.3 ± 5.1 118.8 ± 6.1 116.5 ± 9.1 112.0 ± 9.0
FEV1/FVC ratio as % pred. (%) 76.6 ± 6.0 74.6 ± 7.0 76.3 ± 6.4 72.5 ± 5.4
  1. Data are shown as mean ± standard error of the mean for FVC, FEV1 and FEV1/FVC ratio. *p < 0.05 compared with each control value (Wilcoxon signed-ranks test).